- Home
- / Clinomics
Clinomics
Stock Price
₩593
2024-10-29
Market Capitalization
₩22.8 B
2024-10-29
Revenue
₩8.5 B
FY, 2024
Clinomics Summary
Company Summary
- Overview
- Clinomics (주식회사 클리노믹스) is a biotechnology company that provides genome-based cancer and disease diagnostic solutions. It offers liquid biopsy and precision medicines, genome-based healthcare technology, and big data solutions.
- Type
- Public
- Status
- Active
- Founded
- 2011
- Website
- https://www.clinomics.com
- Cybersecurity rating
Table of Contents
Clinomics Financials
Summary Financials
- Revenue (Q3, 2025)
- ₩2.7B
- Gross profit (Q3, 2025)
- ₩6.2B
- Net income (Q3, 2025)
- ₩1.2B
- Cash (Q3, 2025)
- ₩631.8M
- EBIT (Q3, 2025)
- ₩3.3B
- Enterprise value
- $40.2B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026